y 27632 has been researched along with alprostadil in 4 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 7,136 | 864 | 761 |
| Protein | Taxonomy | y 27632 (IC50) | alprostadil (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
| Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, LJ; Miller, J; Tazzeo, T | 1 |
| Hopps, CV; Mulhall, JP | 1 |
| Wise, H | 1 |
| Adachi, S; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Minamitani, C; Mizutani, J; Natsume, H; Otsuka, T; Tokuda, H | 1 |
1 review(s) available for y 27632 and alprostadil
| Article | Year |
|---|---|
Novel agents for sexual dysfunction.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Alprostadil; Amides; Calcium Channels; Dopamine Agonists; Drug Therapy, Combination; Endothelial Growth Factors; Enzyme Inhibitors; Erectile Dysfunction; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Pyridines; Receptors, Corticotropin; Receptors, Melanocortin; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
3 other study(ies) available for y 27632 and alprostadil
| Article | Year |
|---|---|
Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle.
Topics: Alprostadil; Amides; Animals; Bronchial Arteries; Dinoprost; Dinoprostone; Dioxanes; Dose-Response Relationship, Drug; F2-Isoprostanes; Genistein; Humans; Isoprostanes; Muscle, Smooth, Vascular; Prostaglandins E; Prostaglandins F, Synthetic; Pyridines; Receptors, Thromboxane A2, Prostaglandin H2; Signal Transduction; Swine; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Topics: Adenylyl Cyclases; Alprostadil; Amides; Animals; Cell Line; Cells, Cultured; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Ganglia, Spinal; Humans; Intracellular Signaling Peptides and Proteins; Male; Methyl Ethers; Neurites; Prostaglandin D2; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; rho-Associated Kinases; Time Factors; Tritium | 2006 |
Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 3T3 Cells; Alprostadil; Amides; Animals; Cell Line; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myosin-Light-Chain Kinase; Myosin-Light-Chain Phosphatase; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; rho-Associated Kinases; Vascular Endothelial Growth Factor A | 2009 |